Stay updated on Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page.
Latest updates to the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedDifference0.4%
- Check19 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.5%
- Check26 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference3%
- Check41 days agoChange DetectedThe website has added new features while removing extensive options for downloading study data, including various file formats and detailed data fields.SummaryDifference5%
- Check48 days agoChange DetectedSeveral key resources related to ovarian cancer and treatments, including links to MedlinePlus and Rare Diseases, have been removed from the website.SummaryDifference0.8%
- Check55 days agoChange DetectedThe website has been updated to version 2.12.2, adding numerous resources related to ovarian cancer and clinical trials, including links to MedlinePlus and DailyMed.SummaryDifference6%
Stay in the know with updates to Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page.